News

"The approval of the first vaccine for chikungunya provides a significant solution towards controlling the spread and reducing the disease burden, especially in endemic regions." Doris Nyamwaya, Peter Piot Fellow, LSHTM

News

��ֱ��Ƶ – First chikungunya vaccine approved

Wednesday 22 November 2023

"We must not overlook the really severe cases that can be caused by the chickenpox virus. It is absolutely timely that the UK JCVI has finally recommended a safe and effective vaccine." Beate Kampmann Professor of Paediatric Infection and Immunity, LSHTM

News

��ֱ��Ƶ – Routine chickenpox vaccine recommended for children across UK

Wednesday 15 November 2023

"Based on our modelling analysis, MR-MAPs could prevent 27% - 37% of measles cases and deaths over 10 years." quote by Dr Han Fu

News

��ֱ��Ƶ – Microarray patches could be a cost-effective vaccine innovation in tackling the global measles burden

Tuesday 14 November 2023

News

Meet Edward Parker

Wednesday 8 November 2023

Participants at the VIT retreat in The Gambia

News

Vaccine theme retreat at The Gambia’s MRC Unit

Wednesday 8 November 2023

$“Bacterial-engineered glycoconjugate vaccines can be produced for a fraction of the price of chemical conjugates. Cheaper vaccines are universally beneficial, but the benefits are greater in low-resource settings where the burden of disease is often higher.”$